Fundraising FoxSorbent Therapeutics
Sunnyvale, US · 2 known investors
Find your way into Sorbent Therapeutics
Sign up to see every warm intro you have to Sorbent Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sorbent Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
HC
Howard C. DittrichExecutive
JL
Jason LevinExecutive
TP
Thomas P. O'NeilExecutive
LD
Linda De YoungExecutive
DA
Detlef AlbrechtExecutive
Board
DC
David CollierBoard director
MG
Marcus GoebelBoard director
SM
Scott MinickBoard director
JH
James HealyBoard director
RW
Randall WoodsBoard director
DJ
Donald JosephBoard director
Investors · 2
ARCH Venture PartnersreportedChicago · $50K – $250M
How we know: a partner's Signal profile · funding news · Not right? Tell us
Sofinnova VenturesreportedMenlo Park · $100K – $15M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$6.5M disclosed across 1 round · 2014
▶$6.5MraisedMay 2014 · 10 investors · PharmaceuticalsRule 506(b)
▶$6.5MraisedMay 2014 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Howard C. DittrichExecutive Officer
- Randall WoodsDirector
- Jason LevinExecutive Officer
- Donald JosephDirector
- David CollierDirector
- Marcus GoebelDirector
- Scott MinickDirector
- James HealyDirector
- Thomas P. O'NeilExecutive Officer
- Linda De YoungExecutive Officer
- Detlef AlbrechtExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $6.5M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Sorbent Therapeutics's investors?
- Sorbent Therapeutics's investors include ARCH Venture Partners, Sofinnova Ventures.
- How much funding has Sorbent Therapeutics raised?
- Sorbent Therapeutics has disclosed $6.5M raised across 1 round.
- Where is Sorbent Therapeutics headquartered?
- Sorbent Therapeutics is headquartered in Sunnyvale, US.